| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |